State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023

American Journal of Preventive Medicine · Published 2026-07-01 · DOI 10.1016/j.amepre.2026.108508

Authors (7)

Filmon Wolde, Bradley C. Martin, Mahip Acharya, Laura Gressler, Chenghui Li, Jacob T. Painter, Corey J. Hayes

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wolde, F., Martin, B., Acharya, M., et al. (2026). State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023. American Journal of Preventive Medicine. https://doi.org/10.1016/j.amepre.2026.108508

Related articles